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Abstract
Motivation: Despite more than two decades of research, HIV resistance to drugs remains a serious obstacle in developing efficient 
AIDS treatments. Several computational methods have been developed to predict resistance level from the sequence of viral proteins 
such as reverse transcriptase (RT) or protease. These methods, while powerful and accurate, give very little insight into the molecular 
interactions that underly acquisition of drug resistance/hypersusceptibility. Here, we attempt at filling this gap by using our Monte Carlo 
feature selection and interdependency discovery method (MCFS-ID) to elucidate molecular interaction networks that characterize viral 
strains with altered drug resistance levels.
Results: We analyzed a number of HIV-1 RT sequences annotated with drug resistance level using the MCFS-ID method. This let us 
expound interdependency networks that characterize change of drug resistance to six selected RT inhibitors: Abacavir, Lamivudine, 
Stavudine, Zidovudine, Tenofovir and Nevirapine. The networks consider interdependencies at the level of physicochemical properties 
of mutating amino acids, eg,: polarity. We mapped each network on the 3D structure of RT in attempt to understand the molecular mean-
ing of interacting pairs. The discovered interactions describe several known drug resistance mechanisms and, importantly, some previ-
ously unidentified ones. Our approach can be easily applied to a whole range of problems from the domain of protein engineering.
Availability: A portable Java implementation of our MCFS-ID method is freely available for academic users and can be obtained 
at: http://www.ipipan.eu/staff/m.draminski/software.htm.
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Introduction
For  more  than  two  decades  rapid  emergence  of 
  drug-  resistant mutants remains a serious obstacle to 
designing efficient anti-HIV therapies.   Approximately 
109 new viral particles are produced in a single infected 
individual every day and 3 × 105 mutations emerge in 
this population.1 Some mutations lead to the produc-
tion of functionally impaired viruses whereas other 
give  rise  to  drug-resistant  strains.  Clinical  studies 
have demonstrated that after 2–4 weeks of treatment 
with  anti-HIV  drugs  the  wild-type  virus  is  almost 
completely replaced by drug-resistant strains.2
Currently, 25 different anti-HIV drugs are approved 
for  treatment  and  many  new  drug  candidates  have 
reached phase I and phase II clinical trials. Twelve 
drugs  belong  to  a  group  of  RT  inhibitors  targeted 
against  an  important  viral  enzyme,  reverse  tran-
scriptase (RT).3 Provided with a single-stranded viral 
genome RNA template, the RT catalyzes the synthesis 
of double-stranded proviral DNA. In turn, the proviral 
DNA is incorporated into a host genome, expressed 
and replicated by the native cellular machinery. This 
results in the production of new HIV particles capable 
of infecting other host cells and, thus, completing the 
HIV life cycle.
Two  groups  of  reverse  transcriptase    inhibitors 
are  in  clinical  use,  namely  the  nucleoside/-tide 
RT    inhibitors  (NRTIs)  and  the  non-nucleoside  RT 
inhibitors (NNRTIs). NRTIs mimic dNTPs, the natu-
ral substrates of the RT enzyme, but once incorpo-
rated into a newly synthesized strand, they terminate 
DNA elongation. The members of the second group, 
the NNRTIs inhibit RT by binding in the so-called 
NNRTI-binding  pocket  which,  in  turn,  induces 
  function-disrupting structural changes in the enzyme. 
The  state-of-the-art    highly-active  antiretroviral 
  therapy  (HAART)  regimens  frequently  include  a 
nucleoside RT   inhibitor, a non-nucleoside RT inhibi-
tor and a protease inhibitor.4
A need for new antiviral drugs has been recog-
nized. New generation of drugs should be effective 
against viruses that carry the already known resistance 
mutations. Drugs belonging to the so-called “second 
generation RT inhibitors”, eg, Dapivirine, have been 
introduced recently.5
The availability of resistance-annotated sequence 
data  and  the  inherent  complexity  of  analyzing  the 
560 amino acids of the RT p66 subunit call for an 
  application  of  suitable  computational  methods.  In 
our  previous  study,6  we  have  developed  a  number 
of    rule-based  models  that  relate  mutation-induced 
changes in the physicochemical properties of HIV-1 
RT to the level of resistance to several antiviral drugs. 
A remaining issue was how the individual mutations 
interact in altering resistance.
Approach
We used our interdependency discovery method based 
on  Monte  Carlo  feature  selection  (MCFS-ID)7,8  to 
reveal molecular interaction networks leading to drug 
resistance. It results in a network of resistance-  altering 
molecular  interactions  between  physicochemical 
properties of mutating amino acids. We applied the 
method to find molecular interaction networks that 
underly resistance to six anti-HIV drugs: four nucleo-
side RT inhibitors (Abacavir, Lamivudine, Stavudine, 
Zidovudine); one nucleotide RT inhibitor (Tenofovir) 
and one non-nucleoside RT inhibitor (Nevirapine).
The molecular-interaction networks that we con-
structed are based on thousands of decision-tree clas-
sifiers. Each pair of immediately neighboring nodes 
reflects their joint, statistically valid contribution to 
co-determination of the outcome. We used this fact 
to elucidate molecular interaction networks between 
mutating amino acids.
Methods
Data and discretization
From the Stanford HIV Database9 we obtained a num-
ber of resistance-annotated amino acid sequences of 
HIV-1  reverse  transcriptase  p66  subunit. The  91% 
of the sequences were complete within the first 240 
aa sites, 31% within all the sites. As suggested by 
Zhang et al,10 we used only the sequences with resis-
tance determined by the Monograms® PhenoSense® 
assay.  Following  well  established  clinical  practice, 
we discretized continuous drug resistance values into 
three  classes:  “susceptible”,  “moderately  resistant” 
and “resistant”. Cut-off values used for the discreti-
zation were taken from the work by Rhee et al.9
Description
Rather than modeling the resistance in terms of mut-
ing amino acids (eg, work by   Beerenwinkel et al11), computational analysis of molecular interaction networks
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  we  represent  mutations  as  changes  in  the  physico-
chemical properties of the enzyme. In contrast to the 
approach proposed by Kjaer et al.12 we consequently 
use the same set of descriptors for each class of antivi-
ral drugs. Previously,13,6 we have selected 7   descriptors 
–physicochemical  properties  from  the  aaIndex 
database;14 see Table 1. The descriptors are relatively 
low-correlated (cf. Kierczak et al6), easy to interpret 
by structural biologists and cover various aspects of 
protein  biophysics  including  solvent  interactions, 
thermodynamics, secondary and tertiary structure and 
electrostatic properties. We use the selected properties 
to describe each amino acid in the sequence.
Thus, each sequence is described by 3,920   features 
(560 aa × 7 physicochemical properties). Each amino 
acid in the sequence was encoded as a difference between 
the 7-vector of its properties and the 7-vector repre-
senting properties of the corresponding site in the wild 
type HXB2 reference sequence. Therefore, if no muta-
tion was observed at a given position, it was encoded 
by the zero vector. Our final dataset is an ensemble of 
sequences described in such way and annotated with 
their resistance category. The detailed characteristics of 
each data set are provided in Table 2.
Monte carlo feature selection  
and interdependency discovery
The description step was followed by the selection 
of  significant  resistance-altering  interdependen-
cies between the physicochemical properties of the 
560 amino acids of p66. We applied Monte Carlo 
Feature  Selection  (MCFS)  method  as  described  in 
Dramiński et al.7 In our most recent study,22 we show 
that, unlike Breiman’s Random Forests, our method 
is not biased towards features with many categories. 
The MCFS method relies on the construction of a 
large number of decision trees. We trained the trees 
on s different random subsets of attributes and dif-
ferent random subsets of objects. For each subset, we 
constructed t trees. Each of the trees was trained and 
evaluated on a different, randomly selected training 
set–test set pair. The evaluation results obtained from 
all the s ⋅ t trees let us build a ranking of physico-
chemical properties reflecting their influence on drug-
  resistance. The final ranking of all features does not 
give the information about the cut-off value that sepa-
rates informative features from the non-  informative 
ones.  We  find  the  cut-off  by  applying  Student’s 
t-test  with  its  critical  value  (significance  level  set 
to: P-value ≤ 0.05) determined on a set of rankings 
that have been obtained for data sets with randomly 
permuted values/labels of the class attribute. For the 
detailed description and for the comparison of the 
MCFS method to other feature selection techniques 
see our previous works.6–8
Our approach to interdependency discovery (ID) is 
significantly different from known approaches which 
consist in finding correlations between features or find-
ing groups of features that behave in some sense simi-
larly across samples. A typical bioinformatics example 
of this problem is finding co-regulated features, most 
often genes or, rather more precisely, their expression 
profiles. Searching groups of similar features is usually 
done with the help of various clustering techniques, 
frequently specially tailored to a task at hand.23–26
In  our  approach  to  interdependency  discovery 
(ID) we focus on identifying features that cooper-
ate in determining that a sample belongs to a par-
ticular class. Assume that for a given training set of 
  samples, a rule-based classifier (or a decision tree), 
has been constructed. Now, for each class, a set of 
decision rules defining this class is provided. Each 
decision rule is in fact a conjunction of conditions 
imposed on a particular subset of separate features 
and, thus, points to some interdependencies between 
these features. It is worthwhile to note that in this way 
any  nonlinear  interdependencies  are  sought  which 
Table  1.  Descriptors  of  the  physicochemical  properties 
of amino acids used in this study.
no. Descriptor short name aaindex code
1 Transfer free  
energy from  
octanol to water15
e oct. -wat. RADA880102
2 normalized  
van der Waals 
volume16
vdW vol. FAUJ880103
3 Isoelectric point17 isoel. point ZIMJ680104
4 Polarity18 polarity grAr740102
5 normalized  
frequency of turn19
freq. turn crAJ730103
6 normalized  
frequency  
of alpha-helix20
freq. helix BUrA740101
7 Free energy of  
solution in water21
e sol. wat. CHAM820102Kierczak et al
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best  correlate  with  the  decision  attribute  (within 
regression setting such an approach can be said to 
rely on additive expansion interaction models based 
on regression trees27 (Sec. 2)).
This general idea of looking at interdependencies 
among features seems to be rather plausible but we 
have refined it further, so that it is not dependent on 
just one classifier. In each of the s ⋅ t trees the nodes 
represent features (a given node represents the fea-
ture on which the split is made). For each path in a 
tree, we define the distance between two nodes as the 
number of edges between them. Now, the strength of 
interdependency between two nodes along the same 
path in the tree is defined as the inverse of the dis-
tance  between  them.  For  a  given  pair  of  features, 
the  strength  of  interdependency  between  them  is 
computed as the sum of the strengths between them 
along all paths in all trees (if the two features do not 
appear along a path, the contribution of this path to 
the overall strength is zero). Here, we consider only 
the pairs where the distance d # 3. This value is a 
trade-off between the complexity of reviewing a tree 
and searching for the strongest dependencies. Even-
tually, we normalize every strength by dividing its 
value by the strength-value of the strongest observed 
interdependency.
Since  the  strength  is  calculated  on  the  basis  of 
thousands of trees rather than on the basis of just a 
single classifier, it provides stable and reliable infor-
mation about the degree of the observed interdepen-
dency between the features.
Final results of the analysis are presented in the 
form of graphs where nodes represent features and 
edges  represent  interdependencies.  Only  the  nodes 
corresponding to the informative features are shown. 
An edge connecting two nodes corresponds to the 
observed interaction between them. The interaction 
relation is not transitive, ie, if node A interacts with 
node B and node B interacts with node C, it does not 
imply that node A interacts with node C. It is, how-
ever, plausible that the adjacent pairs of interacting 
nodes co-determine resistance. Nodes corresponding 
to the same aa site occupy the same level and follow 
top to bottom order from N-terminal to C-terminal 
part of the sequence.
We visualize the discovered networks in Figure 1. 
Each node represents a physicochemical property at 
a particular site. Color of a node corresponds to the 
property and the number to the position of the site in 
the RT sequence. For instance (Fig. 1a, leftmost part), 
free energy of solution in water at site 184 interacts 
frequently with either of the following site-property 
pairs: normalized frequency of turn at site 41, isoelec-
tric point at site 41, normalized frequency of turn at 
site 210 or transfer free-energy from octanol to water 
at site 215. These interactions determine the level of 
resistance to Abacavir. Interestingly, all properties but 
polarity appear in the resistance-to-Abacavir network 
at site 184 (Fig. 1a–d). This indicates high degree of 
conservation at the site and points out its central role 
in resistance complexes.
Discussion
We examined the top 20% of interactions among the 
physicochemical properties that contribute to resis-
tance and analyzed these networks in attempt at better 
understanding the combined contribution of individ-
ual mutation-sites. The discovered networks are pre-
sented in Figure 1.
Below  we  provide  a  brief  overview  of  the  RT 
structure and function. Next, we describe structural 
properties of each of the 17 aa residues that occur in 
Table 2. The detailed characteristics of the analyzed datasets. Table summarizes the exact numbers of examples per drug 
and per resistance class.
class Drug susceptible Moderately res. Resistant Total
nrTI Abacavir 198 (28.0%) 321(45.5%) 187 (26.5%) 706
Lamivudine 214 (29.9%) 118 (16.5%) 383 (53.6%) 715
Stavudine 368 (52.1%) 227 (32.2%) 111 (15.7%) 706
Zidovudine 342 (48.6%) 178 (25.3%) 183 (26.0%) 703
ntrTI Tenofovir 230 (66.9%) 76 (22.1%)   38 (11.0%) 344
nnrTI nevirapine 395 (52.9%) 53 (7.1%) 299 (40.0%) 747
Abbreviations: res., resistant; nrTI, nucleoside rT inhibitors; ntrTI, nucleotide rT inhibitors; nnrTI, non-nucleoside rT inhibitors.computational analysis of molecular interaction networks
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the discovered networks. This is followed by an indi-
vidual  discussion  of  each  drug-resistance  network. 
A summary of the findings concludes this section.
The RT is responsible for both RNA-dependent and 
DNA-dependent DNA polymerization. The enzyme 
consists of two subunits: 560 aa-long p66 and 440   
aa-long p51. Although both the subunits share 440 
amino acids, their arrangement and function differ 
significantly: the functional p66 subunit contains a 
DNA-binding groove and the active site whereas p51 
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Figure 1. Interaction networks determining resistance to six hIV-1 rT inhibitors. numbers refer to the aa sites of the rT p66 subunit. colors correspond 
to physicochemical properties.Kierczak et al
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lacks enzymatic activity and serves as a scaffold for 
p66. Mutations in the p66 subunit are responsible for 
the emergence of drug resistance.The ternary structure 
of the p66 subunit is often compared to a right hand con-
sisting of a thumb, a palm and a fingers subdomain.2,5 
These three, together with the connection subdomain, 
are present in both the p55 and the p66 subunits. The 
p66 subunit contains also an RNaseH domain.
The mechanism of polymerization by HIV-1 RT 
is  similar  to  that  described  for  other  DNA  poly-
merases and involves: 1) template/primer binding to 
the enzyme; 2) binding of dNTP and bivalent cations 
(Mg2+) to the RT-template/primer complex; 3) forma-
tion  of  a  phosphodiester  bond  between  the  3’-OH 
primer  terminus  and  the  α-phosphate  of  a  dNTP; 
4) translocation of elongated DNA primer from the 
dNTP binding site to the primer site or release of the 
template/primer  complex.  A  large  conformational 
shift and rotation of the fingers subdomain towards 
the thumb subdomain occurs upon step 2.28,29
Val 75: Lamivudine
Stavudine
Zidovudine
Leu 74: Nevirapine
Met 41: Abacavir
Lamivudine
Glu 203: Abacavir
Tenofovir
Leu 210: Abacavir
Stavudine
Tenofovir Val 179: Nevirapine
Lys 101: Nevirapine
Leu 100: Tenofovir
Arg 211: Nevirapine
Lys 70: Stavudine
Zidovudine
Tyr 181: Nevirapine
Met 184: Abacavir
Lamivudine
Tenofovir
Thr 215: Abacavir
Stavudine
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Lys 219: Tenofovir
Asp 67: Lamivudine
Gly 190: Nevirapine
Leu 228: Lamivudine
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Amino acid site (alpha-carbon)
Novel sites in bold.
different colors used for clarity only
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Legend
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Figure 2. Resistance to RT-inhibitors. (PDB structure: 1RTD). A number of amino acid sites that occur in the resistance networks is mapped onto the 3D 
structure of the HIV-1 RT p66 subunit. For more clarity the structure to the right is rotated 180° novel sites that have not been associated with resistance 
to a particular drug are presented in boldface. For the sake of legibility, the sites that are described on the current panel are presented in red while while 
the sites described on the other panel in grey.
The  palm  subdomain  contains  three  catalyti-
cally active residues: Asp 110, Asp 185 and Asp 186 
embedded in a hydrophobic region.29,30 Both Asp 185 
and Asp 186, together with Tyr 183 and Met184 con-
stitute a highly-conserved YXDD motif found in all 
reverse transcriptases.2
It has been suggested that during polymerization the 
fingers subdomain and both alpha-helices of the thumb 
form a clamp that holds the nucleic acid in the right 
place over the palm. The template/primer interactions 
occur between the sugar-phosphate backbone of the 
DNA/RNA and residues of the p66 subunit.2,28,29
Seventeen different amino acid residues occur in 
the discovered interaction networks (Figs. 1 and 2): 
Met 41, Asp 67, Lys 70, Leu 74, Val 75, Leu 100, 
Lys  101,  Val  179,  Tyr  181,  Met  184,  Gly  190, 
Glu 203, Leu 210, Arg 211, Thr 215, Lys 219 and 
Leu  228.  Mutations  at  residues  100,  101,  179, 
181, 190, 203 and 228 have been associated with 
  resistance to NNRTI drugs.9,31 Mutations at residue   computational analysis of molecular interaction networks
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211 can be found in some non-B HIV subtypes32 
and they are suspected to increase viral fitness by 
alleviating  the  deleterious  effect  of  other  drug-
resistance   mutations.33 Mutations at the remaining 
sites are known to contribute to resistance to NRTI 
drugs.9,3,31
Methionine at residue 184 is located in the close 
vicinity of the catalytic triad and may therefore play 
crucial  role  in  modifying  RT  selectivity  towards 
incoming dNTPs and drug triphosphates (drug-TP). 
Residues Met 41 (inside the 28–44 alpha-helix), Leu 
74 and Val 75 belong to the fingers subdomain, part 
of which is involved in the template positioning.34 
  Residues Asp 67 and Lys 70 belong to the fingers 
domain while residues Leu 210 and Thr 215 are 
embedded inside the palm subdomain and consti-
tute a fragment of the dNTP binding pocket.29 They 
are located opposite to Met 184. Asp 67 remains in 
direct contact with a Mg2+ ion that catalyses enzy-
matic   reaction.30 Glu 203, Leu 210 and Arg 211 are 
all part of the 195–212 alpha-helix. The C-terminal 
part of this helix interacts directly with an incom-
ing dNTP or drug-TP. Leucine 228 is a part of a 
short  (227–229)  beta-strand  in  the  palm  subdo-
main. Leucine 100 is located in the palm, on the 
surface  of  the  NNRTI-binding  pocket.  Mutations 
of Leu 100 give moderate resistance to a number 
of NNRTI drugs.5 Tyrosine residues 181 and 188 
are involved in the ring stacking interaction with 
NNRTIs and their mutations to non-aromatic amino 
acids leads to drug resistance.5 Residues Phe 227, 
Leu  228  and  Trp  229  are  building-blocks  of  the 
NNRTI-binding pocket. Mutations resulting in the 
decrease of chain-bulk at residue 227 lead to loss 
of favorable contacts with some NNRTIs.35 Trypto-
phane 229 apperas to be highly conserved and it has 
been suggested that new generation of drugs should 
interact with this particular residue in order to avoid 
drug resistance.36
Figure 1 presents all the discovered networks that 
we  discuss  below.  Whenever  we  refer  to  a  graph 
by a letter eg, (a)—we refer to this figure. The fol-
lowing  section  discusses  each  RT  inhibitor  indi-
vidually. In supplementary materials, Figure S1, we 
present  the  detailed  information  on  the  distances 
between α-carbon atoms of interdependent and non-
  interdependent significant residues.
Abacavir
Five different amino acid sites: 41, 184, 203, 210 and 
215 are selected by the MCFS-ID method (a)–(d). 
In  graphs: (b),  (c) and  (d),  either of  the 203,  210 
and 215 residues, interacts with residue 184. Each 
of these interactions appears to be a good descriptor 
of the dNTP binding pocket which follows directly 
from the 3D structure of the enzyme, see eg, work by 
Menedez-Arias29 and Figure 2. In graph (a), residue 
184 co-occurs with two sites: 41 and 203. Since Glu 
203 and Leu 210 are parts of the same alpha-helix, 
mutations at site 203 may affect structure and posi-
tion of this helix. Therefore the 184–203 interaction 
may be another good descriptor of the selectivity of 
the pocket. This is further supported by the fact that 
the  normalized  frequency  of  alpha-helix  has  been 
selected at site 203. The second pair (41–184) reflects 
the possible interaction between the binding pocket 
and the fingers subdomain.
Lamivudine
Graphs  (e)–(g),  present  interactions  discovered  for 
Lamivudine. Apart from the already discussed pairs, 
isoelectric point at site 67 and normalized frequency 
of turn at site 228 constitute a pair. Closer look at the 
3D structure (Fig. 2) of the p66 subunit reveals that 
Leu 228 is located inside the short (227–229) beta 
sheet. Mutations disturbing this structure may result 
in repositioning the 178–183 and the 186–191strand. 
This, accompanied by mutations at residue 67, may 
affect substrate selectivity of the enzyme preventing 
incorporation of drug-triphopsphates.
Stavudine
A  new  type  of  interaction  emerges  in  the  case  of 
  Stavudine, another NRTI drug ((h), (i)). Here, normal-
ized frequency of turn at residue 75 (the 71–75 strand) 
co-occurs with free energy of solution in water at resi-
due 215; see graph (h). The latter descriptor charac-
terizes hydrophobic properties of amino acid and its 
emergence in the context of the hydrophobic dNTP-
binding pocket is not surprising. Changes in both the 
electrostatic  properties  and  the  propensity  to  form 
alpha-helix characterize drug-resistance mutations at 
site 210. Interestingly enough, an interaction   involving 
hydrophobicity-related properties at sites 70 and 210 
has been selected by the MCFS-ID; see graph (i).Kierczak et al
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Tenofovir
In the case of Tenofovir (graphs (j)–(l)), a NRTI drug, 
normalized frequency of turn is selected at site 100. 
Mutations  at  this  particular  site  are  typically  con-
nected  with  resistance  to  NNRTI  drugs  only.5,3,31 
It might have emerged as a result of past treatment, 
but it may also play a role in resistance to Tenofovir. 
Although its significance in the context of NRTI drugs 
remains unclear, this in silico discovered interaction 
deserves further attention. The two remaining groups 
of interactions (graphs (k) and (l)) always involve 
site 184 and either of the sites located within or near 
the 195–212 alpha-helix. These interactions seem to 
characterize geometry and general properties of the 
dNTP-binding pocket.
Zidovudine
Interaction of sites 75 and 215 is also important for 
resistance to Zidovudine (graphs (m) and (n)). Here, 
mutations that lead to the change of van der Waals 
  volume  seem  to  matter  (Fig.  2).  Site  215  is  also 
involved in interactions with site 70; see graph (m). 
Both sites are also parts of the dNTP binding pocket.
nevirapine
Several interactions selected as relevant in the case 
of Nevirapine (graphs (o)–(r)) seem to reflect proper-
ties of the NNRTI-binding pocket. Mutations at sites 
100, 101, 181 and 190 are well known to contribute 
to  resistance.3,31  The  selected  interactions  involve 
also  site  74  that  is  associated  with  resistance  to 
NRTI drugs, but not to NNRTIs. The occurrence of 
the 74 site in this context may, again, be the result of 
past treatment. The MCFS-ID selects also sites 179 
and 211. Valine 179 is located in the NNRTI-binding 
pocket and mutations there have been associated with 
drug-resistance.5 Our analysis indicates that changes 
in normalized van der Waals volume play important 
role in the emergence of resistance. Mutations at site 
179 seem to interact with NRTI mutations at site 74 
(graph (q)). Although mutations at site 211 have not 
been reported as contributing to resistance, mutations 
at the adjacent site 210 are well known. It is normal-
ized van der Waals volume that has been selected at 
this position. We can speculate that certain mutations 
at site 211 disrupt the structure of the 195–212 alpha-
helix thus contributing to resistance.
conclusion
We  were  able  to  uncover  and  analyze  several 
  networks  of  molecular  interactions  responsible 
for  the  change  of  resistance  levels  to  six  anti-
viral drugs. The discovered networks encompass 
numerous  previously  known  resistance  mecha-
nisms which is a strong evidence of the validity 
of  the  method.  Significantly,  application  of  the 
MCFS-ID method pinpoints also some new mech-
anisms potentially affecting drug resistance lev-
els. These newly discovered mechanisms deserve 
further experimental investigation. While mecha-
nisms  leading  to  resistance  to    Lamivudine  and 
  Zidovudine  are  described  by  relatively  simple 
networks, resistance to Abacavir and Nevirapine 
appears to be determined in more complex way. 
There are several structural fragments and sites 
that  seem  to  play  central  role  in  altering  resis-
tance. For instance, site 184 plays important role 
in resistance to Abacavir, Lamivudine and Teno-
fovir. Similarily, many members of the 195–212 
helix appear in the discovered networks indicat-
ing its functional importance. On the other hand, 
there are interactions and sites that emerged in the 
context of only one drug eg, 67–228 interaction 
determining resistance to Lamivudine. Some net-
works eg, (l), (o)–(q) contain sites that were asso-
ciated with resistance to another class of drugs. 
These  may  be  the  result  of  past  treatments,  but 
they may also play accessory role that, since dif-
ficult to notify, was previously neglected. It would 
be  highly  interesting  to  include  information  on 
the history of treatment and on viral fitness to our 
analysis.   Unfortunately, there is not enough pub-
licly  available  data  containing  this  information. 
Last but not least, some of the discovered interac-
tions may play compensatory role by increasing 
viral fitness. The novel interactions deserve fur-
ther attention and laboratory validation.
Importantly,  the  method  itself  shows  inter-
actions  between  physicochemical  properties  of 
mutating amino acids. This gives deeper insight 
into  molecular  mechanisms  of  drug  resistance. 
The  majority  of  the  drug  resistance  mutations 
act  simultaneously,  in    cooperative  manner.  The 
MCFS-ID method allows us to see these complex 
interactions. In our opinion the presented approach computational analysis of molecular interaction networks
Bioinformatics and Biology Insights 2010:4  145
can be applied to several similar problems in the 
domain of proteomics.
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supplementary Figure
Distances
41 67 70 74 75 100 101 179 181 184 190 2032 10 2112 15 2192 28
41 0
67 21.42 0
70 14.59 8.00 0
74 13.94 17.141 3.08 0 Mean distance between interdependent pairs: 17.81
75 14.98 20.921 6.68 3.80 0 Mean distance between non-interdependent pairs: 20.77
100 37.22 26.863 2.18 33.363 5.58 0
101 39.81 29.723 5.04 36.80 39.06 3.85 0
179 32.98 28.11 31.443 2.54 34.519 .759 .740
181 29.16 23.482 6.82 26.922 8.90 9.12 11.39 6.23 0
184 21.19 18.842 0.13 17.471 9.20 17.472 0.56 15.419 .760
190 32.79 25.582 9.55 32.71 35.15 9.73 9.44 5.24 8.20 16.710
203 26.22 25.672 6.53 31.773 4.22 22.782 2.84 15.48 17.13 20.04 13.41 0
210 17.26 24.11 22.192 4.71 26.512 6.88 28.151 9.57 18.66 16.48 19.44 10.310
211 18.63 27.742 5.45 26.772 8.14 28.90 29.98 20.82 20.45 18.47 21.42 12.233 .840
215 14.61 18.861 7.04 20.602 2.89 25.502 7.29 19.87 17.59 13.91 19.06 11.925 .318 .910
219 20.99 11.741 4.17 22.712 6.10 22.482 4.29 20.49 17.89 16.52 17.28 14.231 5.271 9.09 11.000
228 29.14 13.65 20.142 5.37 28.601 4.06 16.501 7.32 13.78 15.46 14.12 20.342 3.132 6.50 19.401 1.59 0
Figure s1. Distances between interdependent (grey) and non-interdependent pairs of important residues. Distances (in Å) between alpha-carbon atoms 
were calculated from PDB: 1RTD structure, chain A.